Intensive LDL lowering with evolocumab reduced first heart attack or stroke in diabetes
byMass General BrighamCredit: www.kaboompics.com from PexelsMass General Brigham researchers found that the intensive cholesterol-lowering therapy evolocumab reduced the risk of a first major cardiova
Updated on: May 24,2026
Intensive LDL lowering with evolocumab reduced first heart attack or stroke in diabetes
byMass General BrighamCredit: www.kaboompics.com from PexelsMass General Brigham researchers found that the intensive cholesterol-lowering therapy evolocumab reduced the risk of a first major cardiova
Updated on:May 24,2026
